Your English writing platform
Discover LudwigSuggestions(1)
Exact(58)
Approximately 50% of IGT individuals progress to diabetes over their lifetime, and the annual progression rate varies from 2.3 to 11%, depending on the specific population (17– 19) (20a,21a,29a,61a 72a); in the U.S., ∼41 million individuals have IGT (1).
5, 6 Multi-domain MCI, amnestic MCI (aMCI), and non-amnestic MCI (naMCI) all progress to different types of dementia, with the estimated annual progression rates of 12.2%, 11.7%, and 4.1%, respectively.
In one study, 8 of 33 (24%) youth with IGT at baseline progressed to T2DM during a 2-year period (1), comparable to annual progression rates of 5 10% reported in adults (6).
An annual progression rate of −0.39 D to −0.68 D was reported in school-age children3,4,5.
First-year progression rate and annual progression rate of AVA and of aortic jet velocity (AV-Vel) were calculated.
The median annual progression rate was -0.05 cm(2)/year for AVA and 0.22 m/s/year for AV-Vel.
This second-year model was called the 300B, beginning the annual progression that led to the series being nicknamed "letter cars".
However, most of the population-based studies to date have explored the progression of myopia only by calculating annual progression rates as outcome measurements.
Diabetes and moderate-severe calcification were related to first-year rapid progression.The annual progression rate of severe AS was -0.05 cm(2)/year for AVA and 0.22 m/s/year for AV-Vel.
Similar(2)
The mean annual myopic progression was decreased to 0.05 D compared to 0.84 D in the controls.
"Characterization of Annual Disease Progression of Multiple Sclerosis Patients: A Population-based Study". Freilich, Jonatan, Ali Manouchehrinia, Mark Trusheim, Lynn G. Baird, Sophie Desbiens, Ernst Berndt, and Jan Hillert.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com